| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | UNC0638 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |